- ￥110 - 716
- TargetMol
- T0048
- 2026年07月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶现货试剂/标准品，库存足，周末发货Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- CAS号：
59-26-7
- 规格：
1mLx10mM(inDMSO)/1g/5g/10g/200mg/500mg
| 规格： | 1mLx10mM(inDMSO) | 产品价格： | ￥153.0 |
|---|---|---|---|
| 规格： | 1g | 产品价格： | ￥220.0 |
| 规格： | 5g | 产品价格： | ￥474.0 |
| 规格： | 10g | 产品价格： | ￥716.0 |
| 规格： | 200mg | 产品价格： | ￥110.0 |
| 规格： | 500mg | 产品价格： | ￥158.0 |
Product Introduction
Bioactivity
| 名称 | Nikethamide |
| 描述 | Nikethamide is a stimulant which mainly influences the respiratory cycle. Widely known by its former sales name of Coramine, it was used in the mid-twentieth century as a medical countermeasure against tranquilizer overtreatments, before the advent of endotracheal intubation and positive-pressure lung expansion. It is now thought to be of no value for such purposes, and may be dangerous. |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 45 mg/mL (252.48 mM), Sonication is recommended. |
| 关键字 | Nikethamide | Inhibitor | inhibit | GABAReceptor | GABAR | GABA Receptor |
| 相关产品 | Penicillin G sodium salt | p-Hydroxybenzaldehyde | Valproic acid sodium salt | Valproic Acid | Methionine | Urethane | Methyl eugenol | Dihydromyricetin | (-)-α-Pinene | Imidazoleacetic acid hydrochloride | Baicalin | Nipecotic acid |
| 相关库 | Anti-Cancer Approved Drug Library | Bioactive Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | ReFRAME Related Library | Neurotransmitter Receptor Compound Library | Neuronal Signaling Compound Library | FDA-Approved & Pharmacopeia Drug Library | Approved Drug Library | Drug Repurposing Compound Library | Human Metabolite Library | Anti-Cancer Drug Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验4.32 4.20 4.10 4.03 3.96 3.87 3.77 3.67 3.56 3.45 3.33 9 10 5.46 4.83 4.47 4.24 4.07 3.95 3.85 3.78 3.72 3.62 3.52 3.42 3.31 3.20 3.08 10 11 5.26 4.63 4.27 4.04 3.88 3.76 3.66 3.59 3.53 3.43 3.33 3.23 3.12 3.00 2.88 11 12 5.10 4.47 4.12 3.89
and 59, and individuals with the RR phenotype below 20. freecell 文献里说得很明白：“as proposed by Adkins et al. (26).”。你看看Adkin的这篇文献不就很清楚了么？ zhangzhen66 freecell wrote: 文献里说得很明白：“as proposed by Adkins et al
8.79 8.74 8.71 8.69 8.67 8.66 3 4 7.71 6.94 6.59 6.39 6.26 6.16 6.09 6.04 6.00 5.96 5.91 5.87 5.84 5.82 5.80 4 5 6.61 5.79 5.41 5.19 5.05 4.95 4.88 4.82 4.77 4.74 4.68 4.64 4.60 4.58 4.56 5 6 5.99 5.14 4.76 4.53 4.39 4.28 4.21 4.15 4.10 4.06 4.00
技术资料暂无技术资料 索取技术资料
